Search

Savitha M. Rao

Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )

Most Active Art Unit
1629
Art Unit(s)
1629, 1614, 1621, 1691, 4131
Total Applications
1525
Issued Applications
872
Pending Applications
108
Abandoned Applications
583

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14743741 [patent_doc_number] => 20190255044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-22 [patent_title] => TREATMENT AND PROGNOSTIC MONITORING OF PROLIFERATION DISORDERS USING HEDGEHOG PATHWAY INHIBITORS [patent_app_type] => utility [patent_app_number] => 16/398756 [patent_app_country] => US [patent_app_date] => 2019-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26339 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16398756 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/398756
TREATMENT AND PROGNOSTIC MONITORING OF PROLIFERATION DISORDERS USING HEDGEHOG PATHWAY INHIBITORS Apr 29, 2019 Abandoned
Array ( [id] => 16612065 [patent_doc_number] => 20210030718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-04 [patent_title] => COMBINATIONS FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 17/047931 [patent_app_country] => US [patent_app_date] => 2019-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3724 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047931 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/047931
COMBINATIONS FOR TREATING CANCER Apr 28, 2019 Abandoned
Array ( [id] => 15035471 [patent_doc_number] => 20190328740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => Cancer Treatment Targeted to Tumor Adaptive Responses to Protein Synthesis Stress [patent_app_type] => utility [patent_app_number] => 16/396723 [patent_app_country] => US [patent_app_date] => 2019-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8736 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16396723 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/396723
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress Apr 27, 2019 Issued
Array ( [id] => 15975483 [patent_doc_number] => 10668042 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-02 [patent_title] => Methods of reducing the risk of cardiovascular events in a subject [patent_app_type] => utility [patent_app_number] => 16/391128 [patent_app_country] => US [patent_app_date] => 2019-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 56 [patent_no_of_words] => 60653 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16391128 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/391128
Methods of reducing the risk of cardiovascular events in a subject Apr 21, 2019 Issued
Array ( [id] => 16711892 [patent_doc_number] => 20210079039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => COMPOSITIONS AND METHODS FOR THE SELECTIVE DELIVERY OF THERAPEUTIC AND IMAGING AGENTS [patent_app_type] => utility [patent_app_number] => 17/048078 [patent_app_country] => US [patent_app_date] => 2019-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33672 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -64 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048078 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/048078
COMPOSITIONS AND METHODS FOR THE SELECTIVE DELIVERY OF THERAPEUTIC AND IMAGING AGENTS Apr 15, 2019 Abandoned
Array ( [id] => 14649327 [patent_doc_number] => 20190231792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM [patent_app_type] => utility [patent_app_number] => 16/374081 [patent_app_country] => US [patent_app_date] => 2019-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16618 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 204 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16374081 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/374081
Pharmaceutical compositions comprising meloxicam Apr 2, 2019 Issued
Array ( [id] => 15604147 [patent_doc_number] => 10583113 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-10 [patent_title] => Cromolyn compositions for treatment of pulmonary fibrosis [patent_app_type] => utility [patent_app_number] => 16/370677 [patent_app_country] => US [patent_app_date] => 2019-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 53231 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16370677 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/370677
Cromolyn compositions for treatment of pulmonary fibrosis Mar 28, 2019 Issued
Array ( [id] => 15510137 [patent_doc_number] => 10561635 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-18 [patent_title] => Cromolyn compositions for treatment of pulmonary fibrosis [patent_app_type] => utility [patent_app_number] => 16/370681 [patent_app_country] => US [patent_app_date] => 2019-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 53239 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16370681 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/370681
Cromolyn compositions for treatment of pulmonary fibrosis Mar 28, 2019 Issued
Array ( [id] => 14896857 [patent_doc_number] => 20190292194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-26 [patent_title] => INHIBITORS OF ERK AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/370718 [patent_app_country] => US [patent_app_date] => 2019-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 145190 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16370718 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/370718
INHIBITORS OF ERK AND METHODS OF USE Mar 28, 2019 Abandoned
Array ( [id] => 14578397 [patent_doc_number] => 20190216807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => COMBINATIONS OF A PYRIMIDINE CONTAINING NNRTI WITH RT INHIBITORS [patent_app_type] => utility [patent_app_number] => 16/360693 [patent_app_country] => US [patent_app_date] => 2019-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9266 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360693 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/360693
COMBINATIONS OF A PYRIMIDINE CONTAINING NNRTI WITH RT INHIBITORS Mar 20, 2019 Abandoned
Array ( [id] => 16381904 [patent_doc_number] => 10806714 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-20 [patent_title] => Compositions and methods of use of phorbol esters in the treatment of neoplasms [patent_app_type] => utility [patent_app_number] => 16/360139 [patent_app_country] => US [patent_app_date] => 2019-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17604 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360139 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/360139
Compositions and methods of use of phorbol esters in the treatment of neoplasms Mar 20, 2019 Issued
Array ( [id] => 16428233 [patent_doc_number] => 10828294 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-10 [patent_title] => Compositions and methods for weight loss in at risk patient populations [patent_app_type] => utility [patent_app_number] => 16/356657 [patent_app_country] => US [patent_app_date] => 2019-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6628 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16356657 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/356657
Compositions and methods for weight loss in at risk patient populations Mar 17, 2019 Issued
Array ( [id] => 14990811 [patent_doc_number] => 20190314363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => Compositions And Methods For Reducing Major Adverse Cardiovascular Events [patent_app_type] => utility [patent_app_number] => 16/356663 [patent_app_country] => US [patent_app_date] => 2019-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22181 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16356663 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/356663
Compositions and methods for reducing major adverse cardiovascular events Mar 17, 2019 Issued
Array ( [id] => 14833283 [patent_doc_number] => 20190275042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-12 [patent_title] => FLUOROCYCLOPENTENYLCYTOSINE METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/356328 [patent_app_country] => US [patent_app_date] => 2019-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23125 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16356328 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/356328
FLUOROCYCLOPENTENYLCYTOSINE METHODS OF USE Mar 17, 2019 Abandoned
Array ( [id] => 16498854 [patent_doc_number] => 10864221 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-12-15 [patent_title] => Neuroprotective mixture for mitigating the harmful effects of ischemic stroke [patent_app_type] => utility [patent_app_number] => 16/354994 [patent_app_country] => US [patent_app_date] => 2019-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 3776 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16354994 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/354994
Neuroprotective mixture for mitigating the harmful effects of ischemic stroke Mar 14, 2019 Issued
Array ( [id] => 14929729 [patent_doc_number] => 20190300502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-03 [patent_title] => SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/299722 [patent_app_country] => US [patent_app_date] => 2019-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73012 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16299722 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/299722
SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS Mar 11, 2019 Abandoned
Array ( [id] => 16555647 [patent_doc_number] => 20210000795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => ERGOTHIONEINE COMPOSITIONS AND METHODS FOR MAINTAINING AND/OR INCREASING VITAMIN C LEVELS IN CELLS AND ORGANISMS [patent_app_type] => utility [patent_app_number] => 16/978673 [patent_app_country] => US [patent_app_date] => 2019-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11906 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16978673 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/978673
Ergothioneine compositions and methods for maintaining and/or increasing vitamin C levels in cells and organisms Feb 28, 2019 Issued
Array ( [id] => 16282597 [patent_doc_number] => 20200276199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-03 [patent_title] => INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS [patent_app_type] => utility [patent_app_number] => 16/289515 [patent_app_country] => US [patent_app_date] => 2019-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42025 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 230 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289515 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/289515
INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS Feb 27, 2019 Abandoned
Array ( [id] => 14893695 [patent_doc_number] => 20190290613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-26 [patent_title] => USE OF INDOLE COMPOUNDS FOR FAT REDUCTION AND SKIN AND SOFT TISSUE TIGHTENING [patent_app_type] => utility [patent_app_number] => 16/283985 [patent_app_country] => US [patent_app_date] => 2019-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34597 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16283985 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/283985
Use of indole compounds for fat reduction and skin and soft tissue tightening Feb 24, 2019 Issued
Array ( [id] => 14464395 [patent_doc_number] => 20190183837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-20 [patent_title] => COMPOSITIONS AND METHODS OF USE OF PHORBOLESTERS [patent_app_type] => utility [patent_app_number] => 16/284461 [patent_app_country] => US [patent_app_date] => 2019-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40557 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16284461 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/284461
Compositions and methods of use of phorbolesters Feb 24, 2019 Issued
Menu